Ursula A. Matulonis

机构：Dana-Farber Cancer Institute · ORCID：0000-0002-3103-6992

发表论文 1100 篇 · 总被引 44596 次 · h-index 104

代表论文

• Tamoxifen induces PI3K activation in uterine cancer (2025 · Nature Genetics · 被引 7)
• Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation (2025 · Journal of Clinical Oncology · 被引 4)
• Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial (2025 · Nature Communications · 被引 3)
• Ovarian Sex Cord Tumor With Annular Tubules (SCTAT) Harbor Recurrent Copy Number Alterations, Including Monosomy 22 (2025 · Modern Pathology · 被引 2)
• 547 A phase 1b study of intraperitoneal cytokine-induced memory-like (CIML) natural killer (NK) cell therapy in platinum resistant ovarian cancer (2025 · Regular and Young Investigator Award Abstracts · 被引 1)
• Abstract B004: Phase 1b trial of BCL-XL degrader DT2216 and weekly paclitaxel in recurrent platinum-resistant ovarian cancer (2025 · Molecular Cancer Therapeutics · 被引 1)